In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Biotechnology
US biotech bluebird bio on Friday announced that it has entered into a definitive agreement to sell its second Rare Pediatric Disease Priority Review Voucher (PRV). 7 January 2023
Biotechnology
Privately held Danish biotechnology company MinervaX has appointed Lidia Oostvogels as chief medical officer, bringing a wealth of experience in vaccine development with more than 25 years’ experience in clinical development. 5 January 2023
Pharmaceutical
US cancer specialist Spectrum Pharmaceuticals has lost more than 50% of its stock market value in the past six months, and it has now lost a member of its beleaguered management team, too. 4 January 2023
Biotechnology
A planned merger between US biotech Sesen Bio and privately-held firm Carisma Therapeutics has run into headwinds. 4 January 2023
Biotechnology
Switzerland-based biotech ADC Therapeutics today announced the appointment of Dr Mohamed Zaki as chief medical officer, bringing over 20 years of experience in hematology and oncology drug development to his role. 4 January 2023
Biotechnology
Polish clinical-stage biotech Molecure has announced that Dr Samson Fung, currently chief medical officer, has been appointed to the company’s management board. 4 January 2023
Biotechnology
CAR-T therapy company Allogene Therapeutics has swiftly named its replacement for executive vice president of research and development Rafael Amado, who has resigned to join Sino-American firm Zai Lab. 3 January 2023
Pharmaceutical
Sir Mike Rawlins, a UK pharmacologist who made a massive impact in the field of medicines reimbursement in his own country and internationally, has died at the age of 81. 3 January 2023
Generics
The supervisory board of German drugmaker STADA Arzneimittel has appointed Boris Döbler as group chief financial officer (CFO) with effect from January 1, 2023. 3 January 2023
Biotechnology
Paris, France-based neurodegenerative disease specialist Pharnext has attracted a strategic investment from fellow French firm Néovacs. 29 December 2022
Biotechnology
Belgium’s privately-held biotech Novadip Biosciences today announced the appointment of Judy Ashworth as chief medical office (CMO). 28 December 2022
Pharmaceutical
Danish allergy immunotherapy specialist ALK Abello today announced that Dr Henriette Mersebach will join the company as executive vice president, research and development and member of the board of management. 21 December 2022
Biotechnology
Privately held US clinical-stage biotech Cybrexa Therapeutics today announced the appointment of Michael Needle as chief medical officer. 15 December 2022
Biotechnology
French drug resistance specialist Ribonexus has appointed Steven Powell as chief executive, as the company prepares to seek more financing for its small molecule programs. 14 December 2022
Biotechnology
The retiring Paul Perreault is to be replaced by another Paul as chief executive and managing director of Australian biotech CSL Limited. 13 December 2022
Pharmaceutical
Belgium’s largest pharma company UCB yesterday announces that its board of directors has accepted the resignation of Stefan Oschmann as chairman and board member of the firm. 13 December 2022
Pharmaceutical
At its December meeting today, the board of directors of Swiss pharma giant Roche approved to propose some major board changes at the Annual General Meeting, which will take place on March 14, 2023: 12 December 2022
Biotechnology
Anjarium Biosciences, a Swiss biotech focused on creating and delivering a new class of non-viral gene therapies, has announced the appointment of Otmane Boussif as chief technology officer (CTO). 8 December 2022
Biotechnology
US biotech Mammoth Biosciences, which is building the next generation of CRISPR products to cure and detect disease, has reinforced its C-suite with the arrival of two industry veterans - Phil Tinmouth as chief business officer, and Siang Chin as general counsel. 8 December 2022
Biotechnology
Ireland and USA-based natural killer (NK) cell therapy biotech ONK Therapeutics has named Bruce McCreedy as chief scientific officer (CSO). 6 December 2022
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze